latest news releases from the newsroom
Drott Leases the Former Fysikum Stockholm Facilities to the Swedish Institute for Working Life
STOCKHOLM, Sweden, March 12, 2002 (PRIMEZONE) -- Vanadisvagen 9 (Mimer 5), Stockholm, will be the new address of the Swedish Institute for Working Life, beginning in December 2002. In addition to its core activities of research and development, the Institute will be expanding its educational activities and knowledge dissemination. The move will increase accessibility to the National Working Life Library, which the Institute administers.
Q-Med Deepens the Analysis of the DUROLANE Results
UPPSALA, Sweden, March 12, 2002 (PRIMEZONE) -- Q-Med is deepening the analysis of the results from the DUROLANE/placebo study. A high level of safety shown but it does not show a statistically significant effect of the treatment with DUROLANE compared to sodium chloride solution for the indication osteoarthritis of the knee.
Annual General Meeting of the Shareholders of TV4
STOCKHOLM, Sweden, March 12, 2002 (PRIMEZONE) -- Notice is hereby given that the Annual General Meeting of the Shareholders of TV4 AB (publ) will be held on Wednesday, 10th April 2002 at 9.30am at TV4's headquarters, Tegeluddsvagen 3, Stockholm, Sweden. The premises will open and registration commence at 8.30am.
Parthus Technologies plc
ART's Leading Recognition Technologies Ported to Parthus' Mobile Computing Platform
ATLANTA and DUBLIN, Ireland, March 12, 2002 (PRIMEZONE) -- ART Advanced Recognition Technologies, Inc., recognized global pioneers of natural Human User Interface technologies for the mobile world, and Parthus (Nasdaq:PRTH) (LSE:PRH) a world-leading provider of platform level IP solutions for the mobile Internet market, today announced the porting of ART's speech and handwriting recognition engines to Parthus' InfoStream(TM) platform.
Frontline: Capital Adjustments
OSLO, Norway, March 12, 2002 (PRIMEZONE) -- One employee of Frontline (NYSE:FRO) has exercised options to acquire a total of 5,000 shares in Frontline. All shares have been acquired at a strike price of NOK 30.83 per share. Total proceeds were NOK 154,150.
Personal Chemistry Ltd
Personal Chemistry Acquires License to Scale-Up Technology
UPPSALA, Sweden, March 12, 2002 (PRIMEZONE) -- Personal Chemistry today announced an agreement with CSIRO, the Commonwealth Scientific and Industrial Research Organization, based in Australia, to acquire a license to CSIRO's scale-up technology for the production of compounds developed from Personal Chemistry's Coherent Synthesis(TM) platform. The deal also includes a research agreement in which Personal Chemistry and CSIRO will jointly develop the scale-up technology further.
Karo Bio Receives Award for Prostate Cancer Research
HUDDINGE, Sweden, March 12, 2002 (PRIMEZONE) -- Karo Bio USA, Inc. has received a three year award from the Department of the Army* for drug discovery in prostate cancer. The project applies the Company's novel technological approaches to better define the relationship of androgen receptor (AR) function to prostate cancer in order to discover more effective drugs.